Heron Therapeutics share price logo

Heron Therapeutics

NASDAQ: HRTX

$0.31

+0.01

(+4.10%)

Live

as on

Heron Therapeutics Stock Performance

as on August 20, 2026 at 2:14 am IST

  • Day's Low

    Day's High

    $0.30
    $0.33
    downward going graph

    4.21%

    Downside

    5.36%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.30
    $1.58
    downward going graph

    3.26%

    Downside

    402.87%

    Upside

    downward going graph

Heron Therapeutics share price movements today

Previous Close
$0.30
Open
$0.32
Volume
1.3M
Market Cap
$63.9M
Day's Low - High
$0.30 - $0.33
52 Week Low - High
$0.30 - $1.58

Heron Therapeutics Historical Returns

1 Month Return
-28.47 %
3 Month Return
-60.39 %
1 Year Return
-74.68 %
3 Year Return
-79.22 %
5 Year Return
-96.86 %

Heron Therapeutics Stock Fundamentals & Key Indicators

Check Heron Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$63.9M

EPS (TTM)

-0.13

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

-0.18

EBITDA

-8.7M

Revenue (TTM)

151.2M

Profit Margin

-22.52%

Return On Equity TTM

-2408.88%

Heron Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Heron Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Heron Therapeutics image
Heron Therapeutics
BUY$63.9M-96.86%NA-22.52%NA
Revolution Medicines image
Revolution Medicines
BUY$43.7B669.3%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$128.2B154.86%29.8286.04%NA
Regeneron image
Regeneron
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Heron Therapeutics Stock including INR - Dollar returns

The Heron Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Heron Therapeutics investment value today

Current value as on today

₹25,895

Returns

-₹74,105

(-74.11%)

Returns from Heron Therapeutics Stock

-₹76,451 (-76.45%)

Dollar Impact

₹2,346 (+2.35%)

Analyst Recommendation on Heron Therapeutics Stock

Based on 2 analysts

BUY

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Heron Therapeutics. Average target price of $7

Heron Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Heron Therapeutics.

What analysts predicted

95.53%UPSIDE

Target Price

$7

Current Price

$0.3132

Analyzed by

2 Analysts

Target

$7.00

Heron Therapeutics target price $7, a slight upside of 95.53% compared to current price of $0.3132. According to 2 analysts rating.

Indian Investors' Interest in Heron Therapeutics Stock

Search interest for Heron Therapeutics Stock has increased by 70% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:70% versus previous 30 day period

Heron Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
34
36
32
40
38
37
38
40
34
37
Gross Profit
26
25
23
30
30
27
22
32
24
26
Operating Income
-4
-6
-4
4
3
-1
-4
0
-4
-2
EBITDA
-1
-8
-3
8
3
-1
-13
0
-7
-5
Interest Expense
0
0
0
4
0
0
2
1
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-3
-9
-4
3
2
-2
-17
-2
-8
-5
Income Tax Expense
0
-
-
-
-
-
-
-
-
-
Net Income
-3
-9
-4
3
2
-2
-17
-2
-8
-5
Net Profit Margin
-9.11%
-25.64%
-14.78%
8.98%
6.77%
-6.40%
-45.78%
-7.28%
-23.37%
-14.57%

Heron Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
30
77
145
88
86
107
127
144
154
Gross Profit
1
26
49
84
52
40
52
61
105
113
Operating Income
-170
-194
-183
-210
-228
-217
-174
-110
-11
-2
EBITDA
-169
-192
-182
-201
-225
-214
-171
-103
-5
-17
Interest Expense
2
3
2
1
1
2
2
3
6
9
Depreciation
-
1
1
2
2
3
2
2
2
2
Income Before Tax
-173
-197
-178
-204
-227
-220
-182
-110
-13
-20
Income Tax Expense
-1
3
7
1
-2
-3
-47
2
-
-
Net Income
-173
-197
-178
-204
-224
-217
-134
-110
-13
-20
Net Profit Margin
-13537.37%
-641.87%
-230.84%
-140.27%
-253.20%
-252.08%
-124.93%
-87.02%
-9.41%
-13.04%

Heron Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-9
-4
3
2
-2
-17
-2
-8
-5
Operating Cash Flow
-4
3
-11
-8
-10
1
-9
-1
-2
Investing Cash Flow
2
3
11
2
7
11
-5
0
-3
Financing Cash Flow
0
0
0
0
0
13
0
0
0
Change in Cash
-2
7
0
-6
-2
26
-14
-2
-5

Heron Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-197
-178
-204
-227
-220
-182
-110
-13
-20
Operating Cash Flow
-170
-191
-124
-184
-203
-146
-58
-22
-27
Investing Cash Flow
7
-278
-21
208
32
-3
17
18
16
Financing Cash Flow
293
357
186
9
156
75
54
0
14
Change in Cash
131
-112
40
33
-14
-75
13
-2
2

Mutual Funds that own Heron Therapeutics Stock

Check out the Mutual Funds with significant holdings in Heron Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.952238%
7503417
Fidelity Salem Street Trust
0.903269%
1714878
Fidelity Concord Street Trust
0.884353%
1678966
VANGUARD SCOTTSDALE FUNDS
0.468044%
888593
STATE STREET INSTITUTIONAL FUNDS
0.306222%
581371
See all

Global Institutional Holdings in Heron Therapeutics

Funds
Holdings
Vanguard
4.8%
iShares
3.18%
Felix Baker
2.24%
Schwab
0.45%
SPDR
0.25%
See all

Insights on Heron Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 34.71M → 37.66M (in $), with an average increase of 7.9% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -8.11M → -5.48M (in $), with an average increase of 47.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 629.2% return, outperforming this stock by 711.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 491.1% return, outperforming this stock by 567.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, HRTX stock has moved down by -11.7%

About Heron Therapeutics

Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. Heron Therapeutics, Inc. was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. The company was founded in 1983 and is headquartered in Cary, North Carolina.
OrganisationHeron Therapeutics
Headquarters25 Fenton Main Street, Cary, NC, United States, 27511
IndustryBiotechnology
CEOMr. Craig Alexander Collard
E-voting on sharesClick here to vote

Key Management of Heron Therapeutics

Name

Title

Mr. Craig Alexander Collard

CEO & Director

Mr. Mark E. Hensley

Executive VP & COO

Melissa Jarel

Vice President of Legal

Mr. Brett Fleshman

Chief Business Officer

Ms. Ira Duarte

Executive VP & CFO

Dr. William P. Forbes Pharm. D., Pharm.D.

Executive VP & Chief Development Officer

Mr. Ryan Craig

Vice President of Marketing

Mr. John Aiken

Executive Director of People Management & Training

Dr. John C. Arthur Ph.D.

Senior Vice President of Manufacturing Development

Mr. Robert Sullivan

Chief Commercial Officer

FAQs

What is Heron Therapeutics share price today?

Heron Therapeutics share price today is $0.31 as on . Heron Therapeutics share today touched a day high of $0.33 and a low of $0.30.

What is the 52 week high and 52 week low for Heron Therapeutics share?

Heron Therapeutics share touched a 52 week high of $1.58 on and a 52 week low of $0.30 on . Heron Therapeutics stock price today i.e. is trending at $0.31,which is 80.11% down from its 52 week high and 3.37% up from its 52 week low.

What is Heron Therapeutics's market capitalisation today?

Heron Therapeutics market capitalisation is $0.00T as on .

How to invest in Heron Therapeutics Stock (HRTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Heron Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Heron Therapeutics Shares that will get you 4.7893 shares as per Heron Therapeutics share price of $0.31 per share as on August 19, 2026 at 8:44 pm IST.

What is the minimum amount required to buy Heron Therapeutics Stock (HRTX) from India?

Indian investors can start investing in Heron Therapeutics (HRTX) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in Heron Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Heron Therapeutics share’s latest price of $0.31 as on August 19, 2026 at 8:44 pm IST, you will get 31.9285 shares of Heron Therapeutics. Learn more about fractional shares .

What are the returns that Heron Therapeutics has given to Indian investors in the last 5 years?

Heron Therapeutics stock has given -96.86% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?